Evidence map›Paper›PMID 29281637›Full record

ArticlePLoS genetics2017

Cell envelope stress in mycobacteria is regulated by the novel signal transduction ATPase IniR in response to trehalose.

Maikel Boot, Vincent J C van Winden, Marion Sparrius, Robert van de Weerd, Alexander Speer, Roy Ummels, Tige Rustad, David R Sherman, Wilbert Bitter

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Antibiotics (Basel, Switzerland) · 2023
    Article
  7. The Regulation of ManLAM-Related Gene Expression inInfection and drug resistance · 2022
    Article
  8. Transcriptional regulation and drug resistance inFrontiers in cellular and infection microbiology · 2022
    Review
  9. Pathogens (Basel, Switzerland) · 2020
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Maikel BootDepartment of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, the Netherlands.ORCID 0000-0002-9734-6475
Vincent J C van WindenDepartment of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, the Netherlands.
Marion SparriusDepartment of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, the Netherlands.
Robert van de WeerdDepartment of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, the Netherlands.
Alexander SpeerDepartment of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, the Netherlands.
Roy UmmelsDepartment of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, the Netherlands.
Tige RustadCenter for Infectious Disease, Seattle, Washington, United States of America.ORCID 0000-0003-2996-2943
David R ShermanCenter for Infectious Disease, Seattle, Washington, United States of America.
Wilbert BitterDepartment of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, the Netherlands.ORCID 0000-0001-8347-6511
Amsterdam UMC Location Vrije Universiteit Amsterdam · NLInfectious Disease Research Institute · US

Funding

Technology CoreU19AI106761 · NIAID · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI SHERMAN, DAVID R, ZAK, DANIEL E · 2013 to 2017
$18.9M
NIAID NIH HHS U19 AI106761
6 · The paper itself

Abstract

The cell envelope of mycobacteria is a highly unique and complex structure that is functionally equivalent to that of Gram-negative bacteria to protect the bacterial cell. Defects in the integrity or assembly of this cell envelope must be sensed to allow the induction of stress response systems. The promoter that is specifically and most strongly induced upon exposure to ethambutol and isoniazid, first line drugs that affect cell envelope biogenesis, is the iniBAC promoter. In this study, we set out to identify the regulator of the iniBAC operon in Mycobacterium marinum using an unbiased transposon mutagenesis screen in a constitutively iniBAC-expressing mutant background. We obtained multiple mutants in the mce1 locus as well as mutants in an uncharacterized putative transcriptional regulator (MMAR_0612). This latter gene was shown to function as the iniBAC regulator, as overexpression resulted in constitutive iniBAC induction, whereas a knockout mutant was unable to respond to the presence of ethambutol and isoniazid. Experiments with the M. tuberculosis homologue (Rv0339c) showed identical results. RNAseq experiments showed that this regulatory gene was exclusively involved in the regulation of the iniBAC operon. We therefore propose to name this dedicated regulator iniBAC Regulator (IniR). IniR belongs to the family of signal transduction ATPases with numerous domains, including a putative sugar-binding domain. Upon testing different sugars, we identified trehalose as an activator and metabolic cue for iniBAC activation, which could also explain the effect of the mce1 mutations. In conclusion, cell envelope stress in mycobacteria is regulated by IniR in a cascade that includes trehalose.

Indexed as

Adenosine TriphosphatasesBacterial ProteinsCell MembraneCell WallDNA Transposable ElementsGene Expression Regulation, BacterialGenes, BacterialMutagenesis, InsertionalMycobacterium marinumOperonPromoter Regions, GeneticSignal TransductionTranscription, GeneticTrehaloseAdenosine TriphosphatasesBacterial ProteinsDNA Transposable ElementsTrehalose

Identifiers

PMID29281637
PMCPMC5760070
OpenAlexW2779001380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.